Bioventus, Smith & Nephew's semi-spun-out biologics healing business, is launching its products in Italy, expanding its presence in Europe after getting a foothold in the Netherlands last year.
In 2012, S&N turned its active orthopedic healing unit into a joint venture, retaining 49% ownership and selling the remainder to venture capital firm Essex Woodlands. Bioventus, the resulting JV, sells devices, therapies and diagnostics. "Launch," in this case, is relative, as much Bioventus' work is in relabeling existing S&N products, including the Exogen ultrasound bone-healing system and Durolane osteoarthritis treatment.
To read the entire story click here